Literature DB >> 11054769

Haplotypes at the DRD2 locus and severe alcoholism.

E P Noble1, X Zhang, T L Ritchie, R S Sparkes.   

Abstract

Association studies of the minor TaqI A allele of the D(2) dopamine receptor (DRD2) gene with alcoholism have produced conflicting findings. Failure to assess alcoholics for severity of their disorder and to screen controls for substance use have been proposed as causes for the discrepant results. In the present study, five diallelic sites spanning the DRD2 gene were determined in combined Caucasian (non-Hispanic) studies of more severe alcoholics (n = 92) and controls screened for substance use (n = 85). The frequency of the minor alleles at the 3'-untranslated site (TaqI A) and two intronic sites (TaqI B and intron 6) of the DRD2 gene were each strongly associated with alcoholism. Moreover, the alcoholics compared with the controls at these three sites had a significantly higher frequency of the minor/major allele heterozygote haplotype combination (A1/A2 B1/B2 T/G) than the major allele homozygote haplotype combination (A2/A2 B2/B2 G/G). However, exon 7 and promoter alleles were not associated with alcoholism. In neither the alcoholics nor in the controls were there departures from Hardy-Weinberg equilibrium at any of the five sites examined. The most significant diallelic composite genotypic disequilibria were found when comparisons were made between TaqI A and TaqI B, TaqI A and intron 6, and TaqI B and intron 6 sites. Weaker but still significant disequilibria were observed when TaqI A and exon 7, TaqI B and exon 7, intron 6 and exon 7, and promoter and exon 7 sites were compared. However, no significant disequilibria were noted when TaqI A and promoter, TaqI B and promoter, and intron 6 and promoter sites were compared. In sum, the study found significant evidence for association of the minor alleles in the untranslated sites of the DRD2 gene and their haplotypes with the more severe alcoholic phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054769     DOI: 10.1002/1096-8628(20001009)96:5<622::aid-ajmg7>3.0.co;2-5

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2).

Authors:  Florence F Roussotte; Neda Jahanshad; Derrek P Hibar; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2015-06       Impact factor: 3.978

3.  The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

Authors:  Jacquelyn L Meyers; Emma Nyman; Anu Loukola; Richard J Rose; Jaakko Kaprio; Danielle M Dick
Journal:  Addict Biol       Date:  2012-09-12       Impact factor: 4.280

4.  Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.

Authors:  Yunlong Ma; Wenji Yuan; Xianzhong Jiang; Wen-Yan Cui; Ming D Li
Journal:  Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.590

Review 5.  Reward mechanisms in obesity: new insights and future directions.

Authors:  Paul J Kenny
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

Review 6.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

7.  Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.

Authors:  Claudio A Naranjo; Alan Y Chu; Lescia K Tremblay
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

8.  Between- and within-family association test of the dopamine receptor D2 TaqIA polymorphism and alcohol abuse and dependence in a general population sample of adults.

Authors:  Brett C Haberstick; David Timberlake; Andrew Smolen; Joseph T Sakai; Christian J Hopfer; Robin P Corley; Susan E Young; Michael C Stallings; David Huizinga; Scott Menard; Christy Hartman; Jennifer Grotpeter; John K Hewitt
Journal:  J Stud Alcohol Drugs       Date:  2007-05       Impact factor: 2.582

Review 9.  Dopamine D2 receptors and striatopallidal transmission in addiction and obesity.

Authors:  Paul J Kenny; George Voren; Paul M Johnson
Journal:  Curr Opin Neurobiol       Date:  2013-05-29       Impact factor: 6.627

Review 10.  Candidate genes for cannabis use disorders: findings, challenges and directions.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Addiction       Date:  2009-04       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.